Entera Bio Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 24
Employees
  • Stock Symbol
  • ENTX
Stock Symbol
  • Share Price
  • $1.63
  • (As of Monday Closing)

Entera Bio General Information

Description

Entera Bio Ltd is a clinical-stage biopharmaceutical company which focuses on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The lead oral parathyroid hormone (PTH) product candidate, EB612 for the treatment of hypoparathyroidism. The company also develops a varied oral PTH product candidate, EB613 for the treatment of osteoporosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
NAS
Primary Office
  • Hadassah / Jerusalem Bio Park
  • 5th Floor
  • Jerusalem 9112002
  • Israel

Entera Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Entera Bio Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.63 $1.69 $1.00 - $3.40 $34.3M 21.1M 552K -$0.68

Entera Bio Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 13,093 20,432 63,215
Revenue 246 236 500 0
EBITDA (10,967) (10,557) (10,250) (11,154)
Net Income (11,172) (10,795) (10,304) (11,197)
Total Assets 8,780 16,703 13,341 13,278
Total Debt 216 299 0 3,893
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Entera Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Entera Bio‘s full profile, request access.

Request a free trial

Entera Bio Executive Team (12)

Name Title Board Seat Contact Info
Roger Garceau MD Board Member & Executive
Adam Gridley Chief Executive Officer & Board Member
Spiros Jamas MD Chief Executive Officer
Phillip Schwartz Ph.D Board Member & President
Dana Yaacov-Garbeli Chief Financial Officer, Finance
You’re viewing 5 of 12 executive team members. Get the full list »

Entera Bio Board Members (15)

Name Representing Role Since
Adam Gridley Entera Bio Chief Executive Officer & Board Member 000 0000
Faith Charles JD Self Board Member 000 0000
Gerald Lieberman Self Chairman & Board Member 000 0000
Gerald Ostrov Self Board Member 000 0000
Miranda Toledano Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Entera Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Entera Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Entera Bio‘s full profile, request access.

Request a free trial